FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method of producing a compound of formula [11], or a salt thereof, comprising: (1) a step for reacting a compound of formula [1] or a salt thereof:
where R1 represents a hydrogen atom or an amino protecting group which is selected from C1-6 alkoxycarbonyl group, a chromansulphonyl group substituted with C1-6 alkyl groups, or dihydrobenzofuransulphonyl group substituted with C1-6 alkyl groups; R2 represents C1-6 alkyl group; L1 is a group of formula [18a]
where R5a and R6a are a hydrogen atom and r1 is integer from 1 to 6; and L2 is a group of formula [18b]
where R5b and R6b are a hydrogen atom and r2 is integer from 1 to 6; with a compound of formula [3], or a salt thereof in the presence of a condensing agent
where L3 is a group of formula [18c]
where R5c and R6c represent a hydrogen atom and r3 is integer from 1 up to 6; A1 is any of groups of formulas [4] or [5]:
where * is a binding position; R7 are identical and represent C1-6 alkyl group; and m is integer from 1 to 3; to obtain a compound of formula [10], or a salt thereof:
and (2) a step for deprotection of a compound of formula [10], or a salt thereof in the presence of an acid, to obtain compound [11], in which A2 is any of groups of formulas [12] or [13]:
Invention also relates to a method of producing a metal complex, to a compound of formula [19], to a compound of formula [3], to a compound of formula [11], to a compound of formula [38], to complexes of compounds, structural formulas of compounds are given in the claim.
EFFECT: disclosed is a method of producing novel nitrogen-containing compounds of formula [11], which can be used for treating diseases associated with integrin.
17 cl, 6 dwg, 7 tbl, 27 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF COMPLEX OF NITROGEN-CONTAINING COMPOUND WITH METAL FOR DIAGNOSTICS OR TREATMENT OF TUMORS WITH INTEGRIN EXPRESSION | 2016 |
|
RU2767398C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
ANTAGONISTS OF SOMATOSTATIN RECEPTOR SUBTYPE 5 (SSTR5) | 2014 |
|
RU2671958C2 |
AVB6 INTEGRIN INHIBITORS | 2018 |
|
RU2769702C2 |
NITROIMIDAZOLE DERIVATIVE AGAINST PULMONARY TUBERCULOSIS | 2016 |
|
RU2675622C1 |
THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5HT RECEPTOR LIGANDS AND USE THEREOF | 2007 |
|
RU2434872C2 |
PIPERIDINYL COMPOUNDS FOR SELECTIVE INTEGRINE BINDING | 2003 |
|
RU2333210C2 |
ORGANIC COMPOUNDS | 2015 |
|
RU2702732C1 |
TRICYCLIC COMPOUND AND JAK INHIBITOR | 2015 |
|
RU2674262C2 |
CONDENSED HETEROCYCLIC NITROGEN COMPOUNDS AND USING THEM AS INHIBITORS OF AMYLOID BETA PRODUCTION | 2010 |
|
RU2515976C2 |
Authors
Dates
2020-05-15—Published
2016-03-25—Filed